ストックスクリーナーアプリを入手
21.46
0.35%
0.075
前日終値:
$21.39
開ける：
$21.31
24時間の取引高:
5.35M
Relative Volume:
0.28
時価総額：
$41.19B
収益：
$15.30B
当期純損益:
$1.06B
株価収益率:
39.03
EPS:
0.55
ネットキャッシュフロー:
$1.45B
1週間 パフォーマンス:
+3.40%
1か月 パフォーマンス:
-0.85%
6か月 パフォーマンス:
+1.30%
1年 パフォーマンス:
+17.62%
1日の値動き範囲:
$21.29
$21.53
1週間の範囲:
$20.64
$22.59
52週間の値動き範囲:
$17.85
$25.17
Kenvue Inc Stock (KVUE) Company Profile
名前
Kenvue Inc
電話
908-874-1200
住所
1 KENVUE WAY, SUMMIT
KVUE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
21.47 | 39.74B | 15.30B | 1.06B | 1.45B | 0.55 |
|
PG
Procter Gamble Co
|
152.97 | 370.18B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
60.19 | 149.34B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
87.63 | 74.67B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KMB
Kimberly Clark Corp
|
126.83 | 43.60B | 19.75B | 2.47B | 2.39B | 7.34 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-10 | 開始されました | Redburn Atlantic | Neutral |
| 2025-03-24 | 開始されました | Evercore ISI | In-line |
| 2025-01-06 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2024-09-24 | 開始されました | Jefferies | Buy |
| 2024-09-24 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | 再開されました | Citigroup | Neutral |
| 2024-04-11 | 開始されました | Bernstein | Underperform |
| 2024-04-03 | 開始されました | William Blair | Mkt Perform |
| 2024-03-01 | 再開されました | Goldman | Neutral |
| 2023-11-17 | 開始されました | Piper Sandler | Neutral |
| 2023-09-11 | アップグレード | Deutsche Bank | Hold → Buy |
| 2023-09-07 | 開始されました | Canaccord Genuity | Buy |
| 2023-09-06 | 開始されました | Argus | Hold |
| 2023-08-24 | アップグレード | Goldman | Neutral → Buy |
| 2023-07-25 | 開始されました | Edward Jones | Buy |
| 2023-06-01 | 開始されました | HSBC Securities | Hold |
| 2023-05-30 | 開始されました | BofA Securities | Buy |
| 2023-05-30 | 開始されました | Citigroup | Neutral |
| 2023-05-30 | 開始されました | Deutsche Bank | Hold |
| 2023-05-30 | 開始されました | Exane BNP Paribas | Neutral |
| 2023-05-30 | 開始されました | Goldman | Neutral |
| 2023-05-30 | 開始されました | JP Morgan | Overweight |
| 2023-05-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-05-30 | 開始されました | UBS | Neutral |
すべてを表示
Kenvue Inc (KVUE) 最新ニュース
Legacy Capital Wealth Partners LLC Reduces Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue's Q2 2025 Earnings: What to Expect - Yahoo Finance
Kenvue CEO Thibaut Mongon departs - Storyboard18
Tylenol maker Kenvue fires CEO amid board's strategic review - MSN
Kenvue Initiates CEO Transition and Strategic Review to Drive Shareholder Value - Global Cosmetics News
Tylenol maker Kenvue's CEO quits amid board's strategic review - MSN
Drystone LLC Purchases 58,267 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
M&T Bank Corp Has $2.83 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Citigroup Cuts Kenvue (NYSE:KVUE) Price Target to $22.00 - MarketBeat
Barclays Lowers Kenvue (NYSE:KVUE) Price Target to $22.00 - MarketBeat
Tylenol maker Kenvue ousts CEO amid board's strategic review - MSN
Kenvue Inc. (NYSE:KVUE) Shares Bought by Arizona State Retirement System - MarketBeat
Kenvue Inc. (KVUE) Has “Good Brands,” Says Jim Cramer - MSN
Kenvue's Q2 2025 Earnings: What To Expect - Barchart.com
Kenvue: B of A Securities maintains a 'Buy' Rating, The Target Price is $25 - AInvest
Citi lowers Kenvue stock price target to $22 on CEO transition concerns - Investing.com Canada
Kenvue stock rises as UBS maintains Neutral rating amid CEO change - Investing.com India
Bank of America Cuts Kenvue (NYSE:KVUE) Price Target to $25.00 - MarketBeat
Strategic Shifts and Leadership Changes Position Kenvue, Inc. for Growth: A Buy Rating Justification - TipRanks
Kenvue's Crossroads: Can New Leadership Sustain Dividends Through Strategic Overhaul? - AInvest
Kenvue: New CEO, Watch The Dividend (Rating Downgrade) (NYSE:KVUE) - Seeking Alpha
Kenvue price target lowered to $22 from $23 at Barclays - TipRanks
Kenvue Announces CEO Transition and Strategic Review - The Globe and Mail
Kenvue price target lowered to $25 from $27 at BofA - TipRanks
Kenvue, Inc. Buy Rating Reiterated Amid CEO Transition and Strategic Review - TipRanks
Mutual of America Capital Management LLC Sells 55,866 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Want to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock. - AOL.com
Want to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock. - The Motley Fool
Greenleaf Trust Buys New Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Makes CEO Change Months After Critical Activist Investor Made Proxy Play For Board Seat - insights.citeline.com
Health Care Ticks Down as Merger Activity Offsets Health-Insurance RoutHealth Care Roundup - MarketScreener
Kenvue names interim CEO, launches strategic review - FashionNetwork USA
Kirk Perry Appointed Interim CEO of Kenvue Amid Strategic Review - WWD
Tylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here? - MSN
Kenvue CEO ousted, company announces strategic review - Yahoo Finance
Kenvue's CEO Search and SHB Review Raise Questions, but Core Brands Still Show Stability - Morningstar
Domino's Sets Sights On Faster US Sales While Starbucks Tightens Office Rules - Finimize
Kenvue Surges After Tylenol-Maker Announces Sweeping Changes - MSN
Kenvue Sees Unusually Large Options Volume (NYSE:KVUE) - MarketBeat
Kenvue Makes CEO Change and Acts to Unlock Shareholder Value - New Jersey Business Magazine
Kenvue (NYSE:KVUE) Appoints Kirk Perry As Interim CEO For Transformation Initiative - Yahoo Finance
Kenvue Names Interim CEO, Explores Strategic Options - AInvest
Kenvue (NYSE:KVUE) Shares Gap UpStill a Buy? - MarketBeat
Kenvue Announces CEO Transition - Beauty Packaging
Kenvue Replaces CEO, Forms Strategic-Review Committee. The Stock Rises. - Barron's
Tylenol parent Kenvue has a new CEO, and he has lots of work to do to mollify activist investors - Yahoo Finance
Goldman Sachs maintains Kenvue stock rating at Neutral amid CEO departure - Investing.com Australia
Kenvue CEO Mongon leaves the consumer health company as it continues its strategic review - MSN
Market Voices: White House vs. Powell, EU tariffs, Kenvue's new CEO - Seeking Alpha
Kenvue announces CEO transition and strategic review - Proactive financial news
Kenvue Shares Climb After CEO Exit and Strategic Review Reveal - MSN
Kenvue Inc (KVUE) 財務データ
収益
当期純利益
現金流量
EPS
0.09%
0.76%
大文字化:
|
ボリューム (24 時間):